Dr. Sukhmani K. Padda, an assistant professor of medicine at Stanford University, discusses emerging therapeutic strategies for several rare mutations in NSCLC including ROS1.
Dr. Sukhmani K. Padda, an assistant professor of medicine at Stanford University, discusses emerging therapeutic strategies for several rare mutations in NSCLC including ROS1.